Life Sciences

Marlborough-based pharmaceutical company TheracosBio appointed Jeff McGroarty as its first full-time chief financial officer. His appointment comes following regulatory approval of a new diabetes drug, TheracosBio’s first commercial product.

Marlborough medical device company Candela Corp. has received clearance from the U.S. Food & Drug Administration to use the company’s laster system to treat Melasma, a skin condition frequently arising during pregnancy, among other times.

Hiring remains a challenge at companies still focused on growth and recruitment, in part due to the high cost of living in Massachusetts.

AiM Medical Robotics in Worcester announced on Wednesday it has appointed Gregory Fischer as the company’s new CEO.

UMass Chan Medical School is consolidating its workforce at MassBiologics, its Boston-based biologics and vaccine manufacturing arm. The affected positions will be eliminated in 60 days.

Oligo Factory, a Holliston-based biomanufacturer, opened Thursday a new 13,000 square foot facility to scale-up its production processes. The new facility will serve as Oligo’s new headquarters and will increase manufacturing capabilities for the company by a factor of 12.

RoslinCT and Lykan Bioscience, a combined cell therapy manufacturer, announced Tuesday it is adding six processing suites at its Hopkinton facility. Citing industry demand, the MetroWest and Edinburgh, Scotland based contract developer and manufacturing organization will now have 22 processing suites, with 14 in Hopkinton.

In partnership with State House News Service, the Worcester Business Journal will host a life sciences forum on March 7 at the DCU Center in Worcester.

French pharmaceutical company Sanofi S.A. is laying off 15 workers and discontinuing its COVID-19 vaccine manufacturing at its Framingham facility. 

Sense Biodetection, a COVID-19 testing firm with a facility in Milford, has been acquired by Watertown-based Sherlock Biosciences, a diagnostic testing company that has raised $111 million, including from the Bill & Melinda Gates Foundation.